A carregar...
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases
Preliminary results demonstrated that concurrent sunitinib and stereotactic body radiation therapy (SBRT) is an active regimen for metastases limited in number and extent. This analysis was conducted to determine the long-term survival and cancer control outcomes for this novel regimen. Forty-six pa...
Na minha lista:
| Publicado no: | Target Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4339281/ https://ncbi.nlm.nih.gov/pubmed/23660867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-013-0280-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|